Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 103kWORD 24k
5 January 2016
Question for written answer P-000060-16
to the Commission
Rule 130
Jasenko Selimovic (ALDE)

 Subject:  Antibiotics action plans
 Answer in writing 

With the increased use of antibiotics and the development of more multi-resistant bacteria, the problem of antimicrobial resistance is growing considerably in Europe. In June 2012, the Council agreed that the Member States should ‘develop and implement national strategies or action plans’ for countering antimicrobial resistance. However, the Commission has recently stated that only 24 of the 28 Member States actually have such strategies or plans in place.

In view of this, and of the recently agreed Animal Health Law (which requires ‘prudent and responsible use of veterinary medicines’), together with the current review of Regulation 882/2004/EC, would the Commission consider Member States to be in violation of European legislation (given that Directive 2003/99/EC on the monitoring of zoonoses and zoonotic agents already requires Member States to collect, analyse and submit comparable data as regards the development of antimicrobial resistance on their territory)?

If so, what action does the Commission envisage taking to make Member States develop and implement national strategies for tackling the increasing problem of antimicrobial resistance?

Original language of question: SV 
Legal notice